Home › NDC Lookup › RxCUI directory › RxCUI 1797895

Olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 1797895

RxNorm drug concept · Semantic clinical drug
RxCUI 1797895 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797895
Official nameOlopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asolopatadine hydrochloride 665 MCG/ACTUAT (equivalent to olopatadine 600 MCG/ACTUAT) Metered Dose Nasal Spray; olopatadine HCl 665 MCG/ACTUAT Metered Dose Nasal Spray
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)21,523 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Olopatadine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • These drops are specifically for itchy eyes caused by allergic conjunctivitis — basically when your eyes react to an allergen like pollen, pet dander, or dust. They work to block t...
  • What exactly does olopatadine eye drops treat?
  • The label doesn't specify an exact onset time for the eye drops, but olopatadine gets to work locally in the eye after you apply it. Use them twice a day as directed — every 6 to 8...
  • How quickly will I feel relief after I use them?
📖 Read our full Olopatadine Ophthalmic guide →

🕸️ Concept Web — How Olopatadine hydrochloride 0.665 MG/ACTUAT Metere... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray RxCUI 1797895

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Olopatadine 135391
    • Olopatadine hydrochloride 236599
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • PATANASE 795090
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Olopatadine Metered Dose Nasal Spray 1797894
    • Olopatadine hydrochloride Metered Dose Nasal Spray 2648228
    • Olopatadine Inhalant Product 1159561
    • Olopatadine Nasal Product 1801232
    • Olopatadine hydrochloride Inhalant Product 2663607
    • Olopatadine hydrochloride Nasal Product 2659943
    • Olopatadine Metered Dose Nasal Spray [PATANASE] 1797897
    • Olopatadine hydrochloride Metered Dose Nasal Spray [PATANASE] 2656612
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Olopatadine hydrochloride 0.665 MG/ACTUAT 1797893
    • Olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray [PATANASE] 1797898
    • Olopatadine hydrochloride 0.665 MG/ACTUAT [PATANASE] 1797896

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Olopatadine hydrochloride 0.665 MG/ACTUAT SCDC · 1797893
  • Olopatadine Metered Dose Nasal Spray SCDF · 1797894
  • Olopatadine hydrochloride Metered Dose Nasal Spray SCDFP · 2648228
  • Olopatadine Inhalant Product SCDG · 1159561
  • Olopatadine Nasal Product SCDG · 1801232
  • Olopatadine hydrochloride Inhalant Product SCDGP · 2663607
  • Olopatadine hydrochloride Nasal Product SCDGP · 2659943

Brand-Name Concepts

  • Olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray [PATANASE] SBD · 1797898
  • Olopatadine hydrochloride 0.665 MG/ACTUAT [PATANASE] SBDC · 1797896
  • Olopatadine Metered Dose Nasal Spray [PATANASE] SBDF · 1797897
  • Olopatadine hydrochloride Metered Dose Nasal Spray [PATANASE] SBDFP · 2656612
  • PATANASE Inhalant Product SBDG · 1178165
  • PATANASE Nasal Product SBDG · 1801256
  • PATANASE BN · 795090

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1797895 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0104-01 1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE olopatadine hydrochloride Padagis Israel Pharmaceuticals Ltd 2017-06-14
60505-0845-05 1 BOTTLE in 1 CARTON (60505-0845-5) / 240 SPRAY, METERED in... Olopatadine Hydrochloride Apotex Corp. 2014-10-27
63629-8434-01 1 BOTTLE in 1 CARTON (63629-8434-1) / 240 SPRAY in 1 BOTTLE olopatadine hydrochloride Bryant Ranch Prepack 2021-04-28
65162-0890-23 1 BOTTLE, SPRAY in 1 CARTON (65162-890-23) / 665 SPRAY, MET... Olopatadine Hydrochloride Amneal Pharmaceuticals LLC 2020-02-03
72162-1390-02 1 BOTTLE in 1 CARTON (72162-1390-2) / 240 SPRAY in 1 BOTTLE olopatadine hydrochloride Bryant Ranch Prepack 2023-08-29
Observed labelers: Bryant Ranch Prepack (2) · Amneal Pharmaceuticals LLC (1) · Apotex Corp. (1) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.